Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bachmann

Showing results (271-280 of 517) with videos related to

Pageof 52
Sort By:
American Journal of Medical Genetics. Part A|September 3, 2021
Expanding the phenotype: Four new cases and hope for treatment in Bachmann-Bupp syndromeElizabeth A VanSickle, Julianne Michael, André S Bachmann, et al.
BMC Anesthesiology|August 13, 2016
Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trialAnnika Höcker, Miriam Rabeling, Alexandra Bick, et al.
American Journal of Physiology. Renal Physiology|January 6, 2012
Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limbA Paliege, T Roeschel, H Neymeyer, et al.
Journal of Translational Medicine|August 23, 2011
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomasChristoph Bergmann, Hagen S Bachmann, Agnes Bankfalvi, et al.
Genes|April 3, 2021
Emerging Role of <i>ODC1</i> in Neurodevelopmental Disorders and Brain DevelopmentJeremy W Prokop, Caleb P Bupp, Austin Frisch, et al.
International Journal of Molecular Sciences|June 15, 2017
Hypoxia Inducible Factor-2 Alpha and Prolinhydroxylase 2 Polymorphisms in Patients with Acute Respiratory Distress Syndrome (ARDS)Annika Dötsch, Lewin Eisele, Miriam Rabeling, et al.
Ebiomedicine|November 28, 2020
Gene expression signatures identify paediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unitRama Shankar, Mara L Leimanis, Patrick A Newbury, et al.
RSC Advances|May 2, 2022
Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulationThomas Z Benton, Catherine M Mills, Jonathan M Turner, et al.
Elife|July 20, 2021
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant diseaseSurender Rajasekaran, Caleb P Bupp, Mara Leimanis-Laurens, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2023
Two New Cases of Bachmann-Bupp Syndrome Identified through the International Center for Polyamine DisordersJulianne Michael, Elizabeth VanSickle, Marlie Vipond, et al.
Pageof 52

Showing results (271-280 of 517) with videos related to

Sort By:
Pageof 52
American Journal of Medical Genetics. Part A|September 3, 2021
Expanding the phenotype: Four new cases and hope for treatment in Bachmann-Bupp syndromeElizabeth A VanSickle, Julianne Michael, André S Bachmann, et al.
BMC Anesthesiology|August 13, 2016
Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trialAnnika Höcker, Miriam Rabeling, Alexandra Bick, et al.
American Journal of Physiology. Renal Physiology|January 6, 2012
Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limbA Paliege, T Roeschel, H Neymeyer, et al.
Journal of Translational Medicine|August 23, 2011
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomasChristoph Bergmann, Hagen S Bachmann, Agnes Bankfalvi, et al.
Genes|April 3, 2021
Emerging Role of <i>ODC1</i> in Neurodevelopmental Disorders and Brain DevelopmentJeremy W Prokop, Caleb P Bupp, Austin Frisch, et al.
International Journal of Molecular Sciences|June 15, 2017
Hypoxia Inducible Factor-2 Alpha and Prolinhydroxylase 2 Polymorphisms in Patients with Acute Respiratory Distress Syndrome (ARDS)Annika Dötsch, Lewin Eisele, Miriam Rabeling, et al.
Ebiomedicine|November 28, 2020
Gene expression signatures identify paediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unitRama Shankar, Mara L Leimanis, Patrick A Newbury, et al.
RSC Advances|May 2, 2022
Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulationThomas Z Benton, Catherine M Mills, Jonathan M Turner, et al.
Elife|July 20, 2021
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant diseaseSurender Rajasekaran, Caleb P Bupp, Mara Leimanis-Laurens, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2023
Two New Cases of Bachmann-Bupp Syndrome Identified through the International Center for Polyamine DisordersJulianne Michael, Elizabeth VanSickle, Marlie Vipond, et al.
Pageof 52